Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Stock Report

Market Cap: CN¥14.7b

Guangzhou Kingmed Diagnostics Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yaoming Liang

Chief executive officer

CN¥4.5m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership16.0%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Sep 27
Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

CEO

Yaoming Liang (60 yo)

no data

Tenure

CN¥4,503,500

Compensation

Mr. Yaoming Liang serves as the Chairman of the Board and General Manager of Guangzhou Kingmed Diagnostics Group Co., Ltd. (formerly known as Guangzhou KingMed Center for Clinical Laboratory Co., Ltd) and...


Board Members

NamePositionTenureCompensationOwnership
Yaoming Liang
Chairman & GMno dataCN¥4.50m15.96%
CN¥ 2.3b
Bixi Hao
Deputy GMno dataCN¥2.62m0.011%
CN¥ 1.7m
Linglai Wang
Deputy GM4.8yrsCN¥1.67m0.13%
CN¥ 19.5m
Ting Yan
Deputy GM & Directorno dataCN¥2.29m0.75%
CN¥ 110.7m
Huobao Xie
Independent Directorless than a yearno datano data
Zhanwen Zeng
Directorno dataCN¥1.04m0.75%
CN¥ 110.7m
Qiang Xie
Directorno datano datano data
Jianhua Ling
Independent Directorno dataCN¥264.00kno data
Yongjian Chen
Chairman of the Supervisory Boardno datano datano data
Li Qin Zhou
Supervisorno datano datano data
Xiaofeng Zou
Employee Representative Supervisorno datano datano data
Xia Fan
Independent Directorless than a yearno datano data

0.8yrs

Average Tenure

54.5yo

Average Age

Experienced Board: 603882's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.